Suarez-Fuentetaja et al
158
|
Human |
An observational study measuring serum IDO activity in patients
with heart transplantation |
Patients with acute rejection had higher IDO serum activity
after 1 month of transplantation. Also, IDO serum activity
independently (95% CI, OR 1.4 [1.033-1.876]) predicted graft
rejection among patients with heart transplantation |
Li et al
164
|
Mouse |
Treating animals with dendritic cells transfected with
adenovirus vector carrying IDO gene |
IDO overexpression improved survival, postponed graft rejection,
reduced IFN-γ production, and accelerated CD4+ cell death |
He et al
162
|
Rat |
Treating animals with bone marrow stem cells transfected with
lentiviral vector carrying IDO gene |
IDO overexpression prolonged survival, enhanced ejection
fraction, decreased CD86+, CD80+ cells, MHC II, IL2 and IFN-γ
and increased T Reg cells abundance and the expression of CD274,
IL10, TGF-β1, TGF-β2, TGF-β3 in the heart allograft |
Yang et al
159
|
Rat |
Treating rats with immutol, cyclosporine and 1-MT |
1-MT significantly blocked kynurenine pathway and decreased
graft survival. Activation of kynurenine pathway has been
associated with increased abundance of T Reg cells, higher
concentrations of IL10, and TGF-β, as well as decreased
abundance of CD8+ cells |
Dai et al
171
|
Rat |
A single-dose intravenous administration of 3-hydroxyanthranilic
acid + allogeneic dendritic cells 7 days before heart
transplantation |
Pretreatment with the combination of 3-hydroxyanthranilic
acid + allogeneic dendritic cells enhanced cardiac allograft
survival and suppressed T cells activity |
Lv et al
161
|
Mouse |
Treating mice with dendritic cells transfected with adenovirus
vector carrying IDO gene |
IDO overexpression enhanced both cardiac graft survival and
function. Higher IL10/IL6 ratio and lower levels of IFN-γ and
IL-2 were found in treated group |
Li et al
170
|
Mouse |
Transferring tolerogenic dendritic cells from a tolerant
recipient to secondary recipient in mice heart transplantation
model |
Tolerogenic dendritic cells transfer from a tolerant recipient
to another recipient significantly enhanced IDO expression,
induced T Reg differentiation, suppressed anti-donor T cells
activity and increased graft survival in the secondary
recipient |
Li et al
172
|
Mouse |
Treating mice with intravenous injection of tryptophan catabolic
metabolites, dendritic cells transfected with adenovirus vector
carrying IDO gene and their combination |
Treating mice with tryptophan catabolic metabolites or
adenoviral transfected dendritic cells significantly increased
cardiac graft survival, decreased IL2, TNF-α and IFN-γ and
increased IL10. Significantly greater improvement was observed
in combination therapy |
Yu et al
169
|
Mouse |
Cardiac allograft injection with adenovirus vector carrying IDO
gene. |
Higher IDO expression was detected in treated mice. Increased
IDO expression was associated with decreased expression of IL2,
IL17, and IFN-γ. IDO enhanced T Reg cells differentiation and
prolonged graft survival |
He et al
166
|
Rat |
Intravenous injection of DO1-BMSC-exosomes 48 h after heart
transplantation |
Treated rats showed better cardiac function. Treatment with
DO1-BMSC-exosomes augmented T Reg response and suppressed CD8+
response |
Li et al
176
|
Mouse |
Measuring microRNAs in mice cardiac transplantation and
assessing their effect on cardiac allograft rejection and IDO
expression |
miR-669b-3p decreased IDO expression, thereby expediting graft
rejection |
Sucher et al
167
|
Mouse |
Treating heart transplanted mice with cytotoxic T
lymphocyte-associated antigen-4 Ig (CTLA4Ig) |
CTLA4Ig promoted IDO expression, thereby increasing graft
survival. IDO gene deletion accelerated graft rejection.
Furthermore, IDO inhibition since transplantation or 50 days
after transplantation attenuated the beneficial effects of
CTLA4Ig on graft survival. In addition, T Reg cells depletion
impairs CTLA4Ig-mediated graft survival |
Zhang et al
165
|
Mouse |
Intravenous injection of dendritic cells transfected with
adenovirus vector carrying GDF15 gene 7 days before
transplantation |
GDF15 overexpression upregulated IDO in dendritic cells, thereby
inducing tolerance in T cells and delaying graft rejection |